Vitamin D/VDR Signaling Induces MiR-27a/b Expression in Oral Lichen Planus
Authors
Affiliations
MicroRNA-27a/b are small non-coding RNAs which are reported to regulate inflammatory response and cell proliferation. Although some studies have demonstrated that miR-27b is down-regulated in the oral specimens of patients suffering with oral lichen planus (OLP), the molecular mechanism of miR-27b decrease remains a large mystery, and the expression of miR-27a in OLP is not well explored. Here, we demonstrated both miR-27a and miR-27b, compared with healthy controls, were reduced in the oral biopsies, serum and saliva samples derived from OLP patients. The reductions of miR-27a/b were also confirmed in the lipopolysaccharide (LPS)- or activated CD4 T cell-treated human oral keratinocytes (HOKs). Furthermore, we found vitamin D receptor (VDR) binding sites in the promoters of miR-27a/b genes and verified this finding. We also tested miR-27a/b levels in the oral epithelium from paricalcitol-treated, vitamin D deficient or VDR knockout mice. In the rescue experiments, we confirmed vitamin D and VDR inhibited LPS- or activated CD4 T cell-induced miR-27a/b reductions in HOKs. In sum, our results show that vitamin D/VDR signaling induces miR-27a/b in oral lichen planus.
FTO deficiency facilitates epithelia dysfunction in oral lichen planus.
Fan Y, Hao Y, Ding Y, Wang X, Ge X Mol Ther Nucleic Acids. 2025; 36(1):102463.
PMID: 39995976 PMC: 11847738. DOI: 10.1016/j.omtn.2025.102463.
Koopaie M, Akhbari P, Fatahzadeh M, Kolahdooz S BMC Oral Health. 2024; 24(1):1177.
PMID: 39367474 PMC: 11452954. DOI: 10.1186/s12903-024-04986-0.
Provvisiero D, Negri M, Amatrudo F, Patalano R, Monto T, de Angelis C Int J Obes (Lond). 2024; 48(12):1793-1802.
PMID: 39256615 PMC: 11584397. DOI: 10.1038/s41366-024-01629-w.
Shalaby R, Nawawy M, Selim K, Bahaa S, Refai S, Maksoud A BMC Oral Health. 2024; 24(1):813.
PMID: 39020381 PMC: 11256592. DOI: 10.1186/s12903-024-04239-0.
Fraxin alleviates oral lichen planus by suppressing OCT3-mediated activation of FGF2/NF-κB pathway.
Peng B, Dai Q, Liu X, Jiang S Naunyn Schmiedebergs Arch Pharmacol. 2024; 397(12):10125-10141.
PMID: 38980409 DOI: 10.1007/s00210-024-03270-w.